Search research articles
Contact Us
Filters
Showing results (591-600 of 721) with videos related to
Page
of 73
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
Wolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 14, 2023
Radioligand therapies in cancer: mapping the educational landscape in Europe
Valentina Bugani, Luca Battistelli, Maddalena Sansovini, et al.
The Journal of Urology
|
September 17, 2019
Reply by Authors
Andrea Farolfi, Andrei Gafita, Jeremie Calais, et al.
Nuklearmedizin. Nuclear Medicine
|
February 6, 2023
[Procedure Guideline for Prostate Cancer Imaging with PSMA-ligand PET/CT]
Ali Afshar-Oromieh, Matthias Eiber, Wolfgang Fendler, et al.
Cancer
|
July 20, 2024
Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial
Michael J Morris, Johann de Bono, James Nagarajah, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 25, 2023
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
Patrick Veit-Haibach, Håkan Ahlström, Ronald Boellaard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
Funding Reductions Threaten the Future of Medical Innovation
Johannes Czernin, Carolyn J Anderson, Ramsey Derek Badawi, et al.
Cancers
|
July 29, 2023
Conventional Imaging, MRI and <sup>18</sup>F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
Janna Morawitz, Nils-Martin Bruckmann, Kai Jannusch, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 20, 2021
Changes in the global impact of COVID-19 on nuclear medicine departments during 2020: an international follow-up survey
Francesco Giammarile, Roberto C Delgado Bolton, Noura El-Haj, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 17, 2021
Safety of PSMA-Targeted Molecular Radioligand Therapy with <sup>177</sup>Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)
Jeremie Calais, Johannes Czernin, Pan Thin, et al.
Page
of 73
Search research articles
Search
Showing results (591-600 of 721) with videos related to
Sort By:
Page
of 73
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2022
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
Wolfgang P Fendler, Kim M Pabst, Lukas Kessler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 14, 2023
Radioligand therapies in cancer: mapping the educational landscape in Europe
Valentina Bugani, Luca Battistelli, Maddalena Sansovini, et al.
The Journal of Urology
|
September 17, 2019
Reply by Authors
Andrea Farolfi, Andrei Gafita, Jeremie Calais, et al.
Nuklearmedizin. Nuclear Medicine
|
February 6, 2023
[Procedure Guideline for Prostate Cancer Imaging with PSMA-ligand PET/CT]
Ali Afshar-Oromieh, Matthias Eiber, Wolfgang Fendler, et al.
Cancer
|
July 20, 2024
Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial
Michael J Morris, Johann de Bono, James Nagarajah, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 25, 2023
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
Patrick Veit-Haibach, Håkan Ahlström, Ronald Boellaard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
Funding Reductions Threaten the Future of Medical Innovation
Johannes Czernin, Carolyn J Anderson, Ramsey Derek Badawi, et al.
Cancers
|
July 29, 2023
Conventional Imaging, MRI and <sup>18</sup>F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
Janna Morawitz, Nils-Martin Bruckmann, Kai Jannusch, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 20, 2021
Changes in the global impact of COVID-19 on nuclear medicine departments during 2020: an international follow-up survey
Francesco Giammarile, Roberto C Delgado Bolton, Noura El-Haj, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 17, 2021
Safety of PSMA-Targeted Molecular Radioligand Therapy with <sup>177</sup>Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)
Jeremie Calais, Johannes Czernin, Pan Thin, et al.
Page
of 73